Violation Tracker Individual Record
Date:October 17, 2016
Primary Offense:False Claims Act and related
Secondary Offense:kickbacks and bribery
Omnicare Inc. agreed to pay $28.125 million to resolve allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the prescription drug, Depakote, for nursing home patients.
Level of Government:federal
Action Type:agency action
Agency:Justice Department Civil Division
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Rhode Island
Ownership Structure of Parent:publicly traded
Major Industry of Parent:retailing
Specific Industry of Parent:retail-pharmacies
Source of Data:
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.